slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,95 EUR | 0,00% | +1,03% | -35,87% |
Omzet 2024 * | 1,05 mln. 1,12 mln. | Omzet 2025 * | 1,6 mln. 1,71 mln. | Marktkapitalisatie | 17,92 mln. 19,16 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 | Nettowinst (verlies) 2025 * | 1 mln. 1,07 mln. | EV/omzet 2024 * | 17,5 x |
Nettoschuld 2024 * | 450K 481K | Nettoschuld 2025 * | 10,55 mln. 11,28 mln. | EV/omzet 2025 * | 17,8 x |
K/w-verhouding 2024 * |
-2,09
x | K/w-verhouding 2025 * |
-3,11
x | Werknemers | 68 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,14% |
Recentste transcriptie over PHAXIAM Therapeutics S.A.
1 week | +1,03% | ||
Lopende maand | -1,01% | ||
1 maand | +1,72% | ||
3 maanden | -28,05% | ||
6 maanden | -33,41% | ||
Lopend jaar | -35,87% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thibaut du Fayet
CEO | Chief Executive Officer | 56 | 23-06-23 |
Eric Soyer
DFI | Director of Finance/CFO | 57 | 23-06-23 |
Pascal Birman
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 63 | 23-06-23 | |
Hilde Windels
BRD | Director/Board Member | 59 | 23-06-23 |
Gil Beyen
BRD | Director/Board Member | 62 | 23-06-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 2,95 | 0,00% | 16 261 |
25-04-24 | 2,95 | +1,20% | 941 |
24-04-24 | 2,915 | -0,17% | 1 540 |
23-04-24 | 2,92 | -0,68% | 1 047 |
22-04-24 | 2,94 | +0,68% | 731 |
slotkoers Euronext Paris, 26 april 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-35,87% | 19,13 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |